Regulatory Roundup: Device Ban Supported; Obesity Device Panel; Eyelid Weights
This article was originally published in The Gray Sheet
Executive Summary
FDA neuro panel supports FDA’s proposed ban of electrical stimulation devices used for “aversive conditioning.” The agency has officially scheduled an advisory panel meeting to consider EnteroMedics’s PMA for the implantable Maestro Rechargeable System as a weight-loss tool in obese patients. More regulatory news.